CT-image-based genetic testing is a simple EGFR mutation prediction method providing reproducible results and facilitates the early detection of gene mutations, which can improve the prognosis of NSCLC patients and help establish personalized treatment strategies. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.